Matches in SemOpenAlex for { <https://semopenalex.org/work/W3159681920> ?p ?o ?g. }
- W3159681920 endingPage "2143" @default.
- W3159681920 startingPage "2143" @default.
- W3159681920 abstract "All-trans retinoic acid (ATRA) and valproic acid (VP) have been tried in the treatment of non-promyelocytic variants of acute myeloid leukemia (AML). Non-randomized studies suggest that the two drugs can stabilize AML and improve normal peripheral blood cell counts. In this context, we used a proteomic/phosphoproteomic strategy to investigate the in vivo effects of ATRA/VP on human AML cells. Before starting the combined treatment, AML responders showed increased levels of several proteins, especially those involved in neutrophil degranulation/differentiation, M phase regulation and the interconversion of nucleotide di- and triphosphates (i.e., DNA synthesis and binding). Several among the differentially regulated phosphorylation sites reflected differences in the regulation of RNA metabolism and apoptotic events at the same time point. These effects were mainly caused by increased cyclin dependent kinase 1 and 2 (CDK1/2), LIM domain kinase 1 and 2 (LIMK1/2), mitogen-activated protein kinase 7 (MAPK7) and protein kinase C delta (PRKCD) activity in responder cells. An extensive effect of in vivo treatment with ATRA/VP was the altered level and phosphorylation of proteins involved in the regulation of transcription/translation/RNA metabolism, especially in non-responders, but the regulation of cell metabolism, immune system and cytoskeletal functions were also affected. Our analysis of serial samples during the first week of treatment suggest that proteomic and phosphoproteomic profiling can be used for the early identification of responders to ATRA/VP-based treatment." @default.
- W3159681920 created "2021-05-10" @default.
- W3159681920 creator A5000695612 @default.
- W3159681920 creator A5021294750 @default.
- W3159681920 creator A5021608571 @default.
- W3159681920 creator A5026896159 @default.
- W3159681920 creator A5034690361 @default.
- W3159681920 creator A5070277644 @default.
- W3159681920 creator A5077582884 @default.
- W3159681920 date "2021-04-29" @default.
- W3159681920 modified "2023-09-24" @default.
- W3159681920 title "Proteomic Studies of Primary Acute Myeloid Leukemia Cells Derived from Patients Before and during Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid and Valproic Acid" @default.
- W3159681920 cites W1487070667 @default.
- W3159681920 cites W1967358345 @default.
- W3159681920 cites W1968552183 @default.
- W3159681920 cites W1974667981 @default.
- W3159681920 cites W1981896167 @default.
- W3159681920 cites W1984839420 @default.
- W3159681920 cites W1988201825 @default.
- W3159681920 cites W1993489631 @default.
- W3159681920 cites W1994328316 @default.
- W3159681920 cites W1997525257 @default.
- W3159681920 cites W1998682097 @default.
- W3159681920 cites W2003877984 @default.
- W3159681920 cites W2017286526 @default.
- W3159681920 cites W2017993597 @default.
- W3159681920 cites W2018872127 @default.
- W3159681920 cites W2022962406 @default.
- W3159681920 cites W2023010129 @default.
- W3159681920 cites W2023322396 @default.
- W3159681920 cites W2030155066 @default.
- W3159681920 cites W2035603803 @default.
- W3159681920 cites W2036059406 @default.
- W3159681920 cites W2036180243 @default.
- W3159681920 cites W2036321220 @default.
- W3159681920 cites W2037199116 @default.
- W3159681920 cites W2043274355 @default.
- W3159681920 cites W2043874839 @default.
- W3159681920 cites W2044303805 @default.
- W3159681920 cites W2045203330 @default.
- W3159681920 cites W2051415279 @default.
- W3159681920 cites W2062939612 @default.
- W3159681920 cites W2068556430 @default.
- W3159681920 cites W2071934663 @default.
- W3159681920 cites W2072165179 @default.
- W3159681920 cites W2077263250 @default.
- W3159681920 cites W2078901327 @default.
- W3159681920 cites W2080752012 @default.
- W3159681920 cites W2081576971 @default.
- W3159681920 cites W2083436346 @default.
- W3159681920 cites W2086402500 @default.
- W3159681920 cites W2089749985 @default.
- W3159681920 cites W2091273971 @default.
- W3159681920 cites W2091437674 @default.
- W3159681920 cites W2108060278 @default.
- W3159681920 cites W2115494923 @default.
- W3159681920 cites W2118597946 @default.
- W3159681920 cites W2119703760 @default.
- W3159681920 cites W2122914905 @default.
- W3159681920 cites W2123356418 @default.
- W3159681920 cites W2126139729 @default.
- W3159681920 cites W2126525177 @default.
- W3159681920 cites W2129304314 @default.
- W3159681920 cites W2131943909 @default.
- W3159681920 cites W2133639929 @default.
- W3159681920 cites W2135581618 @default.
- W3159681920 cites W2139657402 @default.
- W3159681920 cites W2141478391 @default.
- W3159681920 cites W2147054306 @default.
- W3159681920 cites W2148763013 @default.
- W3159681920 cites W2148921332 @default.
- W3159681920 cites W2153058974 @default.
- W3159681920 cites W2155696324 @default.
- W3159681920 cites W2156645168 @default.
- W3159681920 cites W2158266834 @default.
- W3159681920 cites W2159507916 @default.
- W3159681920 cites W2159675211 @default.
- W3159681920 cites W2161186281 @default.
- W3159681920 cites W2164469747 @default.
- W3159681920 cites W2164912656 @default.
- W3159681920 cites W2169472932 @default.
- W3159681920 cites W2192530289 @default.
- W3159681920 cites W2226913284 @default.
- W3159681920 cites W2260297624 @default.
- W3159681920 cites W2276640786 @default.
- W3159681920 cites W2409872168 @default.
- W3159681920 cites W2428790343 @default.
- W3159681920 cites W2463195069 @default.
- W3159681920 cites W2468664272 @default.
- W3159681920 cites W2537623931 @default.
- W3159681920 cites W2554076267 @default.
- W3159681920 cites W2559537906 @default.
- W3159681920 cites W2683363718 @default.
- W3159681920 cites W2728020099 @default.
- W3159681920 cites W2739874266 @default.
- W3159681920 cites W2751461709 @default.
- W3159681920 cites W2782237780 @default.
- W3159681920 cites W2795366323 @default.